A new model of neonatal stress which produces lasting neurobehavioral effects in adult rats

Neonatology

Volumn 92, Issue 1, 2007, Pages 33-41

  McPherson, Ronald J ^a   Gleason, Christine ^a   Mascher Denen, Marcella ^a   Chan, Michelle ^a   Kellert, Brian ^a   Juul, Sandra E ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Inhibitory avoidance; Neonatal hypoxia ischemia; Opiate

Indexed keywords

CORTICOSTERONE; MORPHINE SULFATE; NITROGEN; OXYGEN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; COGNITION; COGNITIVE DEFECT; COLD EXPOSURE; CONTROLLED STUDY; FEMALE; FORCED SWIMMING TEST; GROWTH RETARDATION; HEMATOCRIT; HYPEROXIA; HYPOXIA; LEARNING DISORDER; MALE; MATERNAL DEPRIVATION; MORTALITY; NEONATAL STRESS; NEWBORN; NEWBORN INTENSIVE CARE; NONHUMAN; PASSIVE AVOIDANCE; PERINATAL DEVELOPMENT; PERINATAL PERIOD; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; TASK PERFORMANCE;

ANALGESICS, OPIOID; ANIMALS; ANIMALS, NEWBORN; ANOXIA; BEHAVIOR, ANIMAL; BLOOD PRESSURE; COGNITION DISORDERS; COLD; CORTICOSTERONE; DISEASE MODELS, ANIMAL; FEMALE; HEMATOCRIT; HUMANS; INTENSIVE CARE UNITS, NEONATAL; MALE; MATERNAL DEPRIVATION; MORPHINE; RATS; RATS, SPRAGUE-DAWLEY; STRESS;

ANIMALIA; RATTUS;

EID: 34347350131     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000100084     Document Type: Article

References (59)

1. Barker DJ, Osmond C, Golding J, Kuh D, Wadsworth ME: Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ 1989;298:564-567.
2. Barker DJ, Shiell AW, Barker ME, Law CM: Growth in utero and blood pressure levels in the next generation. J Hypertens 2000;18:843-846.
3. Boloker J, Gertz SJ, Simmons RA: Gestational diabetes leads to the development of diabetes in adulthood in the rat. Diabetes 2002;51:1499-1506.
4. Simmons RA, Templeton LJ, Gertz SJ: Intrauterine growth retardation leads to the development of type 2 diabetes in the rat. Diabetes 2001;50:2279-2286.
5. Alexander GR, Kogan M, Bader D, Carlo W, Allen M, Mor J: US birth weight/gestational age-specific neonatal mortality: 1995-1997 rates for whites, Hispanics, and blacks. Pediatrics 2003;111:e61-e66.
6. Anderson BJ, Palmer GM: Recent developments in the pharmacological management of pain in children. Curr Opin Anaesthesiol 2006;19:285-292.
7. Menon G, Anand KJ, McIntosh N: Practical approach to analgesia and sedation in the neonatal intensive care unit. Semin Perinatol 1998;22:417-424.
8. Peabody JL, Martin GI: From how small is too small to how much is too much. Ethical issues at the limits of neonatal viability. Clin Perinatol 1996;23:473-489.
9. Prevention and management of pain and stress in the neonate. American Academy of Pediatrics. Committee on Fetus and Newborn. Committee on Drugs. Section on Anesthesiology. Section on Surgery. Canadian Paediatric Society. Fetus and Newborn Committee. Pediatrics 2000;105:454-461.
10. Anand KJ, Aranda JV, Berde CB, Buckman S, Capparelli EV, Carlo W, Hummel P, Johnston CC, Lantos J, Tutag-Lehr V, Lynn AM, Maxwell LG, Oberlander TF, Raju TN, Soriano SG, Taddio A, Walco GA: Summary proceedings from the neonatal pain-control group. Pediatrics 2006;117(3 Pt 2):S9-S22.
11. Clancy GT, Anand KJ, Lally P: Neonatal pain management. Crit Care Nurs Clin North Am 1992;4:527-535.
12. Carbajal R, Lenclen R, Jugie M, Paupe A, Barton BA, Anand KJ: Morphine does not provide adequate analgesia for acute procedural pain among preterm neonates. Pediatrics 2005;115:1494-1500.
13. Anand KJ, Hall RW, Desai N, Shephard B, Bergqvist LL, Young TE, Boyle EM, Carbajal R, Bhutani VK, Moore MB, Kronsberg SS, Barton BA: Effects of morphine analgesia in ventilated preterm neonates: primary outcomes from the NEOPAIN randomised trial. Lancet 2004;363:1673-1682.
14. Hall RW, Kronsberg SS, Barton BA, Kaiser JR, Anand KJ: Morphine, hypotension, and adverse outcomes among preterm neonates: who's to blame? Secondary results from the NEOPAIN trial. Pediatrics 2005;115:1351-1359.
15. Orsini AJ, Leef KH, Costarino A, Dettorre MD, Stefano JL: Routine use of fentanyl infusions for pain and stress reduction in infants with respiratory distress syndrome. J Pediatr 1996;129:140-145.
16. Quinn MW, Wild J, Dean HG, Hartley R, Rushforth JA, Puntis JW, Levene MI: Randomised double-blind controlled trial of effect of morphine on catecholamine concentrations in ventilated pre-term babies. Lancet 1993;342:324-327.
17. Anand KJ: Consensus statement for the prevention and management of pain in the newborn. Arch Pediatr Adolesc Med 2001;155:173-180.
18. Simons SH, van Dijk M, van Lingen RA, Roofthooft D, Duivenvoorden HJ, Jongeneel N, Bunkers C, Smink E, Anand KJ, van den Anker JN, Tibboel D: Routine morphine infusion in preterm newborns who received ventilatory support: a randomized controlled trial. JAMA 2003;290:2419-2427.
19. Anand KJ, Scalzo FM: Can adverse neonatal experiences alter brain development and subsequent behavior? Biol Neonate 2000;77:69-82.
20. Loizzo A, Loizzo S, Lopez L, d'Amore A, Renzi P, Spampinato S, Di Carlo S, Bacosi A, Zuccaro P, Pacifici R: Naloxone prevents cell-mediated immune alterations in adult mice following repeated mild stress in the neonatal period. Br J Pharmacol 2002;135:1219-1226.
21. Smart JL, Dobbing J: Vulnerability of developing brain. II. Effects of early nutritional deprivation on reflex ontogeny and development of behaviour in the rat. Brain Res 1971;28:85-95.
22. Sternberg WF, Scorr L, Smith LD, Ridgway CG, Stout M: Long-term effects of neonatal surgery on adulthood pain behavior. Pain 2005;113:347-353.
23. Heinrichs SC, Koob GF: Application of experimental stressors in laboratory rodents; in Crawley JN, et al (eds): Current Protocols In Neuroscience. New York, Wiley & Sons, 2001.
24. Brunson KL, Kramar E, Lin B, Chen Y, Colgin LL, Yanagihara TK, Lynch G, Baram TZ: Mechanisms of late-onset cognitive decline after early-life stress. J Neurosci 2005;25:9328-9338.
25. Bailey CC, Kitchen I: Developmental responses to opioids reveal a lack of effect on stress-induced corticosterone levels in neonatal rats. Br J Pharmacol 1987;91:119-125.
26. Sonderegger TB, Bromley B, Zimmermann E: Effects of morphine pellet implantation in neonatal rats. Proc Soc Exp Biol Med 1977;154:435-438.
27. Lapointe G, Nosal G: Morphine treatment during rat pregnancy: neonatal and preweaning consequences. Biol Neonate 1982;42:22-30.
28. Kornblum HI, Loughlin SE, Leslie FM: Effects of morphine on DNA synthesis in neonatal rat brain. Brain Res 1987;428:45-52.
29. Seatriz JV, Hammer RP Jr: Effects of opiates on neuronal development in the rat cerebral cortex. Brain Res Bull 1993;30:523-527.
30. Handelmann GE, Dow-Edwards D: Modulation of brain development by morphine: effects on central motor systems and behavior. Peptides 1985;6(suppl 2):29-34.
31. Hammer RP Jr, Ricalde AA, Seatriz JV: Effects of opiates on brain development. Neurotoxicology 1989;10:475-483.
32. Kirby ML, DeRossett SE, Holtzman SG: Enhanced analgesic response to morphine in adult rats exposed to morphine prenatally. Pharmacol Biochem Behav 1982;17:1161-1164.
33. Hu S, Sheng WS, Lokensgard JR, Peterson PK: Morphine induces apoptosis of human microglia and neurons. Neuropharmacology 2002;42:829-836.
34. Slotkin TA, Anderson TR: Sympatho-adrenal development in perinatally addicted rats. Addict Dis 1975;2:293-306.
35. Tsang D, Ng SC: Effect of antenatal exposure to opiates on the development of opiate receptors in rat brain. Brain Res 1980;188:199-206.
36. Wimpey TL, Opheim KE, Chavkin C: Effects of chronic morphine administration on the mu and delta opioid responses in the CA1 region of the rat hippocampus. J Pharmacol Exp Ther 1989;251:405-411.
37. Adamson WT, Windh RT, Blackford S, Kuhn CM: Ontogeny of mu- and kappa-opiate receptor control of the hypothalamo-pituitary-adrenal axis in rats. Endocrinology 1991;129:959-964.
38. Thornton SR, Compton DR, Smith FL: Ontogeny of mu opioid agonist anti-nociception in postnatal rats. Brain Res Dev Brain Res 1998;105:269-276.
39. Castellano C, Ammassari-Teule M: Prenatal exposure to morphine in mice: enhanced responsiveness to morphine and stress. Pharmacol Biochem Behav 1984;21:103-108.
40. Messer M, Thoman EB, Galofre A, Dallman T, Dallman PR: Artificial feeding of infant rats by continuous gastric infusion. J Nutr 1969;98:404-410.
41. Barlow B, Santulli TV: Importance of multiple episodes of hypoxia or cold stress on the development of enterocolitis in an animal model. Surgery 1975;77:687-690.
42. Kalinichev M, Easterling KW, Holtzman SG: Early neonatal experience of Long-Evans rats results in long-lasting changes in morphine tolerance and dependence. Psychopharmacology (Berl) 2001;157:305-312.
43. Kalinichev M, Easterling KW, Holtzman SG: Repeated neonatal maternal separation alters morphine-induced antinociception in male rats. Brain Res Bull 2001;54:649-654.
44. Bammer G: Pharmacological investigations of neurotransmitter involvement in passive avoidance responding: a review and some new results. Neurosci Biobehav Rev 1982;6:247-296.
45. Silva MT: Extinction of a passive avoidance response in adrenalectomized and demedullated rats. Behav Biol 1973;9:553-562.
46. Silva RH, Abilio VC, Takatsu AL, Kameda SR, Grassl C, Chehin AB, Medrano WA, Calzavara MB, Registro S, Andersen ML, Machado RB, Carvalho RC, Ribeiro Rde A, Tufik S, Frussa-Filho R: Role of hippocampal oxidative stress in memory deficits induced by sleep deprivation in mice. Neuropharmacology 2004;46:895-903.
47. Silva RH, Felicio LF, Nasello AG, Vital MA, Frussa-Filho R: Effect of ganglioside (GM1) on memory in senescent rats. Neurobiol Aging 1996;17:583-586.
48. McIntyre CK, Power AE, Roozendaal B, McGaugh JL: Role of the basolateral amygdala in memory consolidation. Ann N Y Acad Sci 2003;985:273-293.
49. Ferry B, Roozendaal B, McGaugh JL: Role of norepinephrine in mediating stress hormone regulation of long-term memory storage: a critical involvement of the amygdala. Biol Psychiatry 1999;46:1140-1152.
50. McGaugh JL, McIntyre CK, Power AE: Amygdala modulation of memory consolidation: interaction with other brain systems. Neurobiol Learn Mem 2002;78:539-552.
51. Wan RQ, Wiegant VM, de Jong W, de Wied D: Alterations of beta-endorphin-like immunoreactivity in CSF following behavioral training using a passive avoidance procedure. Psychoneuroendocrinology 1996;21:503-513.
52. Gonzalez AS, Rodriguez Echandia EL, Cabrera R, Foscolo MR, Fracchia LN: Neonatal chronic stress induces subsensitivity to chronic stress in adult rats. I. Effects on forced swim behavior and endocrine responses. Physiol Behav 1990;47:735-741.
53. Cowdrey CR, Wright GW Jr, Kleinerman J: The attempted experimental production of pulmonary emphysema in rats by forced swimming. Am Rev Respir Dis 1963;87:444-448.
54. Porsolt RD: Animal model of depression. Biomedicine 1979;30:139-140.
55. Borsini F, Lecci A, Sessarego A, Frassine R, Meli A: Discovery of antidepressant activity by forced swimming test may depend on preexposure of rats to a stressful situation. Psychopharmacology (Berl) 1989;97:183-188.
56. van Dijken HH, Mos J, van der Heyden JA, Tilders FJ: Characterization of stress-induced long-term behavioural changes in rats: evidence in favor of anxiety. Physiol Behav 1992;52:945-951.
57. McLaughlin JP, Li S, Valdez J, Chavkin TA, Chavkin C: Social defeat stress-induced behavioral responses are mediated by the endogenous kappa opioid system. Neuropsychopharmacology 2006;31:1241-1248.
58. Holmes PV: Rodent models of depression: reexamining validity without anthropomorphic inference. Crit Rev Neurobiol 2003;15:143-174.
59. West AP: Neurobehavioral studies of forced swimming: the role of learning and memory in the forced swim test. Prog Neuropsychopharmacol Biol Psychiatry 1990;14:863-877.